HIV Vaccine Phase 1 Trial Begins in the US and South Africa
National Institutes of Health
Novel vaccine uses weakened cytomegalovirus as a vector to deliver and alert the immune system
Novel vaccine uses weakened cytomegalovirus as a vector to deliver and alert the immune system
Research confirms the safety and effectiveness of the first child-friendly single fixed-dose combination HIV treatment
Most LGBTQ+ advocates welcome FDA’s proposed blood donor eligibility guidance, despite its flaws